Suchergebnisse - "Hill, Nathan R"

PubPharm (58)

1

Undertaking multi-centre randomised controlled trials in primary care : learnings and recommendations from the PULsE-AI trial researchers

enthalten in: BMC primary care | 2024

von Pollock, K. | Dickerson, C. | Kainth, M. | +15

2

Correction : Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial

enthalten in: Trials | 2022

von Hill, N. | Lasserson, D. | Thompson, B. | +13

ErratumFor: Trials. 2014 May 08;15:160. - PMID 24886488

3

Correction: Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial–a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial

enthalten in: Trials | 2022

von Hill, N. | Lasserson, D. | Thompson, B. | +13

4

Correction: Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial–a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial

enthalten in: Trials | 2022

von Hill, N. | Lasserson, D. | Thompson, B. | +13

5

Budget impact analysis of a machine learning algorithm to predict high risk of atrial fibrillation among primary care patients

enthalten in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology | 2022

von Szymanski, T. | Ashton, R. | Sekelj, S. | +6

6

Identification of undiagnosed atrial fibrillation using a machine learning risk-prediction algorithm and diagnostic testing (PULsE-AI) in primary care : a multi-centre randomized controlled trial in England

enthalten in: European heart journal. Digital health | 2022

von Hill, N. | Groves, L. | Dickerson, C. | +18

7

Identification of undiagnosed atrial fibrillation using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI) in primary care : cost-effectiveness of a screening strategy evaluated in a randomized controlled trial in England

enthalten in: Journal of medical economics | 2022

von Hill, N. | Groves, L. | Dickerson, C. | +17

8

Detecting undiagnosed atrial fibrillation in UK primary care : Validation of a machine learning prediction algorithm in a retrospective cohort study

enthalten in: European journal of preventive cardiology | 2021

von Sekelj, S. | Sandler, B. | Johnston, E. | +7

CommentIn: Eur J Prev Cardiol. 2021 May 22;28(6):596-597. - PMID 33624085

9

An observational study of international normalized ratio control according to NICE criteria in patients with non-valvular atrial fibrillation : the SAIL Warfarin Out of Range Descriptors Study (SWORDS)

enthalten in: European heart journal. Cardiovascular pharmacotherapy | 2021

von Harris, D. | Thayer, D. | Wang, T. | +6

CommentIn: Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):e20. - PMID 33537748

10

Application of a machine learning algorithm for detection of atrial fibrillation in secondary care

enthalten in: International journal of cardiology. Heart & vasculature | 2020

von Pollock, K. | Sekelj, S. | Johnston, E. | +6

1
2
3
4
5
6
Nächster »
[6]